Antibody drug conjugates: lessons from 20 years of clinical experience-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antibody drug conjugates: lessons from 20 years of clinical experience

Published:2016-12 Issue:12 Volume:27 Page:2168-2172
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Tolcher A.W.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/27/12/2168/8623074/mdw424.pdf

Reference41 articles.

1. Antibody-drug conjugate—an emerging class of cancer treatment;Diamantis;Br J Cancer,2015

2. Antibody-drug conjugates—a new wave of cancer drugs;Bouchard;Bioorganic Med. Chem Lett,2014

3. Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates;Trail;Science,1993

4. Phase I study of monoclonal antibody-ricin A chain immnoconjugate Xomazyme-791 in patients with metastatic colon cancer;LoRusso;Am J Clin Oncol,1995

5. Treatment of advanced solid tumorswith immunotoxin LMB-1: An antibody linked to pseudomonas exotoxin;Pai;Nat Med,1996

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expanding horizons in cancer therapy by immunoconjugates targeting tumor microenvironments;Critical Reviews in Oncology/Hematology;2024-09

2. Ocular adverse events associated with antibody-drug conjugates in oncology: a pharmacovigilance study based on FDA adverse event reporting system (FAERS);Frontiers in Pharmacology;2024-08-20

3. Single-Domain Antibodies as Antibody–Drug Conjugates: From Promise to Practice—A Systematic Review;Cancers;2024-07-27

4. Advancing Tumor-Targeted Chemo-Immunotherapy: Development of the CAR-M-derived Exosome-Drug Conjugate;Journal of Medicinal Chemistry;2024-07-23

5. FAP Radioligand Linker Optimization Improves Tumor Dose and Tumor-to-Healthy Organ Ratios in 4T1 Syngeneic Model;Journal of Medicinal Chemistry;2024-07-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3